Lipid Integration in Neurodegeneration: An Overview of Alzheimer’s Disease

Molecular Neurobiology

Volumn 50, Issue 1, 2014, Pages 168-176

  Yadav, Rajesh Singh ^a   Tiwari, Neeraj Kumar ^b  

^a DR H S GOUR UNIVERSITY   (India)

^b SHRI RAMSWAROOP MEMORIAL UNIVERSITY   (India)

Author keywords

Alzheimer s disease; Ceramide; Lipid rafts; Neurodegeneration; Oxidative stress; Sphingomyelin

Indexed keywords

AMYLOID; LIPID;

ALZHEIMER DISEASE; DISEASE ASSOCIATION; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID RAFT; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SYNAPTIC TRANSMISSION; BRAIN; DEGENERATIVE DISEASE; HOMEOSTASIS; METABOLISM; NERVE CELL; PHYSIOLOGY;

ALZHEIMER DISEASE; BRAIN; HOMEOSTASIS; HUMANS; LIPID METABOLISM; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS;

EID: 84911006426     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8661-5     Document Type: Review

References (96)

1. Campbell NA, Mitchell LG, Reece JB (1999) Biology, 5th edn. Benjamin/Cummings Publ. Co., Inc, Menlo Park
2. Schroepfer G (1981) Sterol biosynthesis. Annu Rev Biochem 50:585–621
3. Lees N, Skaggs B, Kirsch D, Bard M (1995) Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae—a review. Lipids 30(3):221–226
4. Fahy E, Subramaniam S, Murphy R et al (2009) Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 50(Supplement):S9–S14
5. Subramaniam S, Fahy E, Gupta S et al (2011) Bioinformatics and systems biology of the lipidome. Chem Rev 111(10):6452–6490
6. Coleman RA, Lee DP (2004) Enzymes of triglyceride synthesis and their regulation. Prog Lipid Res 43(2):134–176
7. Zachowski A (1993) Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 294(Pt 1):1–14
8. Farooqui AA, Horrocks LA, Farooqui T (2000) Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids 106(1):1–29
9. Berridge MJ, Irvine RF (1989) Inositol phosphates and cell signalling. Nat J 341(1):197–205
10. Bach D, Wachtel E (2003) Phospholipid/cholesterol model membranes: formation of cholesterol crystallites. Biochim Biophys Acta 1610(2):187–197
11. Haughey NJ, Bandaru VVR, Bai M, Mattson MM (2010) Roles for dysfunctional sphingolipid metabolism in Alzheimer’s disease neuropathogenesis. Biochim Biophys Acta 1801(8):878–886
12. Jana A, Hogan EL, Pahan K (2009) Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci 278(1–2):5–15
13. Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EM Jr (2002) Lipid rafts in neuronal signaling and function. Trends Neurosci 8:412–417
14. Mencarelli C, Martinez-Martinez P (2013) Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci 70:181–203
15. Wang X (2004) Lipid signaling. Curr Opinions Plant Biol 7(3):329–336
16. Dinasarapu AR, Saunders B, Ozerlat I, Azam K, Subramaniam S (2011) Signaling gateway molecule pages a data model perspective. Bioinformatics 27(12):1736–1738
17. Eyster KM (2007) The membrane and lipids as integral participants in signal transduction. Adv Physiol Educ 31(1):5–16
18. Hinkovska-Galcheva V, VanWay SM, Shanley TP, Kunkel RG (2008) The role of sphingosine-1-phosphate and ceramide-1-phosphate in calcium homeostasis. Curr Opin Investig Drugs 9(11):1192–1205
19. Saddoughi SA, Song P, Ogretmen B (2008) Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 49:413–440
20. Klein C, Malviya AN (2008) Mechanism of nuclear calcium signaling by inositol 1,4,5-trisphosphate produced in the nucleus, nuclear located protein kinase C and cyclic AMP-dependent protein kinase. Front Biosci 13(13):1206–1226
21. Boyce JA (2008) Eicosanoids in asthma, allergic inflammation, and host defense. Cur Mo Med 8(5):335–349
22. Cutler RG, Kelly J, Storie K et al (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci U S A 101:2070–2075
23. Sultana R, Perluigi M, Butterfield DA (2013) Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med 62:157–169
24. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569–572
25. Brown DA, London E (2000) Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221–17224
26. Pike LJ (2008) The challenge of lipid rafts. J Lipid Res 50:S323
27. Korade Z, Kenworthy AK (2008) Lipid rafts, cholesterol, and the brain. Neuropharmacology 55(8):1265–1273
28. Brown DA, London E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111–136
29. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39
30. Kamiguchi H (2006) The region-specific activities of lipid rafts during axon growth and guidance. J Neurochem 98(2):330–335
31. Grider MH, Park D, Spencer DM, Shine HD (2009) Lipid raft-targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively. J Neurosci Res 87:3033–3042
32. Munderloh C, Solis GP, Bodrikov V et al (2009) Reggies/flotillins regulate retinal axon regeneration in the zebra fish optic nerve and differentiation of hippocampal and N2a neurons. J Neurosci 29:6607–6615
33. Petro KA, Schengrund CL (2009) Membrane raft disruption promotes axonogenesis in N2a neuroblastoma cells. Neurochem Res 34:29–37
34. Cordy JM, Hooper NM, Turner AJ (2006) The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol 23(1):111–122
35. Cheng H, Vetrivel KS, Gong et al (2007) Mechanisms of disease: new therapeutic strategies for Alzheimer’s disease—targeting APP processing in lipid rafts. Nat Clin Pract Neurol 3:374–382
36. Vetrivel KS, Thinakaran G (2010) Membrane rafts in Alzheimer’s disease β-amyloid production. Biochim Biophys Acta 1801:860–867
37. Han X, Holtzman MD, McKeel DW Jr, Kelley J, Morris JC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis. J Neurochem 82:809–818
38. Car H, Zendzian-Piotrowska M, Fiedorowicz A, Prokopiuk S, Sadowska A, Kurek K (2012) The role of ceramides in selected brain pathologies: ischemia/hypoxia, Alzheimer disease. Postepy Hig Med Dosw 66:295–303
39. Wenk GL (2003) Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 64(9):7–10
40. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118(1):5–36
41. Honjo K, Black SE, Verhoeff NP (2012) Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. Can J Neurol Sci 39(6):712–728
42. Breunig JJ, Guillot-Sestier MV, Town T (2013) Brain injury, neuroinflammation and Alzheimer's disease. Front Aging Neurosci 5:26
43. Fadil H, Borazanci A, Ait Ben Haddou E, Yahyaoui M, Korniychuk E, Jaffe SL, Minagar A (2009) Early onset dementia. Int Rev Neurobiol 84:245–262
44. Jorge RE, Robinson RG (2011) Treatment of late-life depression: a role of non-invasive brain stimulation techniques. Int Rev Psychiatry 23(5):437–444
45. Selkoe DJ (1994) Alzheimer’s disease: a central role for amyloid. J Neuropathol Exp Neurol 53(5):438–447
46. Hamlin AS, Windels F, Boskovic Z, Sah P, Coulson EJ (2013) Lesions of the basal forebrain cholinergic system in mice disrupt idiothetic navigation. PLoS One 8(1):e53472
47. Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383–421
48. Ariga T, McDonald MP, Yu RK (2008) Role of ganglioside metabolism in the pathogenesis of Alzheimer’s disease—a review. J Lipid Res 49:1157–1175
49. Ariga T, Jarvis WD, Yu RK (1998) Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 39:1–16
50. Cherayil GD (1968) Fatty acid composition of brain glycolipids in Alzheimer’s disease, senile dementia, and cerebrocortical atrophy. J Lipid Res 9:207–214
51. Hicks DA, Nalivaeva NN, Turner AJ (2012) Lipid rafts and Alzheimer’s disease: protein-lipid interactions and perturbation of signalling. Front Physiol 3(189):1–18
52. Lukiw WJ, Bazan NG (2008) Docosahexaenoic acid and the aging brain. J Nutr 138:2510–2514
53. Bazan NG (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photo-receptors. Trends Neurosci 29:263–271
54. Suzuki K, Katzman R, Korey SR (1965) Chemical studies on Alzheimer’s disease. J Neuropathol Exp Neurol 24:211–224
55. Nitsch RM, Blusztajn JK, Pittas AG et al (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A 89:1671–1675
56. Bassett CN, Montine TJ (2003) Lipoproteins and lipid peroxidation in Alzheimer's disease. J Nutr Health Aging 7(1):24–29
57. He X, Huang Y, Li B, Gong CX, Schuchman EH (2010) Deregulation of sphingolipid metabolism in Alzheimer’s disease. Neurobiol Aging 31(3):398–408
58. Satoi H, Tomimoto H, Ohtani R et al (2005) Astroglial expression of ceramide in Alzheimer’s disease brains: a role during neuronal apoptosis. Neuroscience 130:657–666
59. Markesbery WR (1999) The role of oxidative stress in Alzheimer disease. Arch Neurol 56:1449–1451
60. Lovell MA, Xie C et al (2000) Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 29(8):714–720
61. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9(1):133–146
62. Hardas SS, Sultana R, Clark AM et al (2013) Oxidative modification of lipoic acid by HNE in Alzheimer’s disease brain. Redox Biol 1:80–85
63. Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer's disease amyloid β peptide. Biochim Biophys Acta 1768:1976–1990
64. Schonfeld E, Yasharel I, Yavin E, Brand A (2007) Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in pc12 cells. Neurochem Res 32:1673–1684
65. Brand A, Schonfeld E, Isharel I, Yavin E (2008) Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage. J Neurochem 105:1325–1335
66. Poli G, Schaur RJ (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50(4–5):315–321
67. Sayre LM, Zelasko DA, Harris PL et al (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68:2092–2097
68. Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ (1997) 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol 56:866–871
69. Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 27:1094–1099
70. Stadtman ER, Berlett BS (1997) Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 10:485–494
71. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45:358–368
72. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer’s disease. Neuroreport 5(18):2529–2533
73. Pappolla MA, Omar RA, Kim KS, Robakis NK (1992) Immunohistochemical evidence of oxidative stress in Alzheimer’s disease. Am J Pathol 140:621–628
74. Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101(3):577–599
75. Bazan NG, Calandria JM, Gordon WC (2013) Docosahexaenoic acid and its derivative neuroprotectin D1 display neuroprotective properties in the retina, brain and central nervous system. Nestle Nutr Inst Workshop Ser 77:121–131
76. Giasson BI, Sampathu DM, Wilson CA et al (2002) The environmental toxin arsenite induces tau hyperphosphorylation. Biochemistry 41(51):15376–15387
77. Borenstein AR, Copenhaver CI, Mortimer JA (2006) Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 20(1):63–72
78. Jones N (2010) Alzheimer disease: risk of dementia and Alzheimer disease increases with occupational pesticide exposure. Nat Rev Neurol 6(7):353
79. Wingo TS, Rosen A, Cutler DJ, Lah JJ, Levey AI (2012) Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases. Neurobiol Aging 33(1):204, e13–15
80. Namgung U, Xia Z (2001) Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol Appl Pharmacol 174:130–138
81. Hull M, Lieb K, Fiebich BL (2002) Pathways of inflammatory activation in Alzheimer’s disease: potential targets for disease modifying drugs. Curr Med Chem 9:83–88
82. Gong G, O’bryant SE (2010) The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis Assoc Disord 24:311–316
83. Gharibzadeh S, Hoseini SS (2008) Arsenic exposure may be a risk factor for Alzheimer's disease. J Neuropsychiatry Clin Neurosci 20(4):501
84. Yadav RS, Chandravanshi LP, Shukla RK et al (2011) Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology 32:760–768
85. Ansari RW, Shukla RK, Yadav RS et al (2012) Cholinergic dysfunctions and enhanced oxidative stress in the neurobehavioral toxicity of lambda-cyhalothrin in developing rats. Neurotox Res 22:292–309
86. Sankhwar ML, Yadav RS, Shukla RK et al (2012) Impaired cholinergic mechanisms following exposure to monocrotophos in young rats. Hum Exp Toxicol 31(6):606–616
87. Eberhardt JL, Persson BR, Brun AE, Salford LG, Malmgren LO (2008) Blood-brain barrier permeability and nerve cell damage in rat brain 14 and 28 days after exposure to microwaves from GSM mobile phones. Electromagn Biol Med 27:215–229
88. Eulitz C, Ullsperger P, Freude G, Elbert T (1998) Mobile phones modulate response patterns of human brain activity. Neuroreport 9:3229–3232
89. Freude G, Ullsperger P, Eggert S, Ruppe I (1998) Effects of microwaves emitted by cellular phones on human slow brain potentials. Bioelectromagnetics 19:384–387
90. Koivisto M, Krause CM, Revonsuo A, Laine M, Hamalainen H (2000) The effects of electromagnetic field emitted by GSM phones on working memory. Neuroreport 11:1641–1643
91. Smythe JW, Costall B (2003) Mobile phone use facilitates memory in male, but not female, subjects. Neuroreport 14:243–246
92. Trosic I, Busljeta I, Modlic B (2004) Investigation of the genotoxic effect of microwave irradiation in rat bone marrow cells: in vivo exposure. Mutagenesis 19:361–364
93. Lee TM, Ho SM, Tsang LY et al (2001) Effect on human attention of exposure to the electromagnetic field emitted by mobile phones. Neuroreport 12:729–731
94. Krause CM, Sillanmaki L, Koivisto M et al (2000) Effects of electromagnetic fields emitted by cellular phones on the electroencephalogram during a visual working memory task. Int J Radiat Biol 76:1659–1667
95. Krause CM, Sillanmaki L, Koivisto M et al (2000) Effects of electromagnetic field emitted by cellular phones on the EEG during a memory task. Neuroreport 11(2000b):761–764
96. Kesari KK, Siddiqui MH, Meena R, Verma HN, Kumar S (2013) Cell phone radiation exposure on brain and associated biological systems. Indian J Exp Biol 51(3):187–200